The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes
Primary Purpose
Diabetes Mellitus, Type 2
Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Treated and educated by nurses specialized in diabetes.
Sponsored by

About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring Randomized controlled trial, Delegation, Professional, Nurses
Eligibility Criteria
Inclusion Criteria:
- patients with DM2 who were referred by GPs to the diabetes outpatient clinics
Exclusion Criteria:
- macroalbuminuria
- serum creatinine level > 135 mol/l,
- Cockcroft < 50 ml/min
- alanine aminotransferase (ALT) > 120 U/l
- pregnant woman
Sites / Locations
- Isala Clinics
Outcomes
Primary Outcome Measures
mean decrease in:
HbA1c
blood pressure
total cholesterol
LDL cholesterol
cholesterol/HDL-ratio
proportion of patients achieving ranges of:
glycaemic control
lipid profile
Secondary Outcome Measures
health related quality of life (HRQOL)
diabetes related symptoms
patients' satisfaction
health care consumption and costs
Full Information
NCT ID
NCT00394875
First Posted
October 31, 2006
Last Updated
October 31, 2006
Sponsor
Medical Research Foundation, The Netherlands
Collaborators
Netherlands: Ministry of Health, Welfare and Sports, Langerhans Foundation, the Netherlands
1. Study Identification
Unique Protocol Identification Number
NCT00394875
Brief Title
The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes
Official Title
The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes in a Secondary Care Setting: a Randomized Controlled Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
October 2006
Overall Recruitment Status
Completed
Study Start Date
March 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
January 2005 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Medical Research Foundation, The Netherlands
Collaborators
Netherlands: Ministry of Health, Welfare and Sports, Langerhans Foundation, the Netherlands
4. Oversight
5. Study Description
Brief Summary
To determine whether the management of type 2 diabetes mellitus (DM2) can be transferred from an internist to a supervised nurse specialized in diabetes (NSD) with a comparable quality of clinical care, health care costs, health related quality of life (HRQOL), and patient satisfaction.
Detailed Description
Diabetes mellitus type 2 (DM2) is a chronic, progressive illness which causes considerable morbidity and premature mortality.1-2 The worldwide prevalence of DM2 is high and is increasing steadily, also in The Netherlands.3-4 The burden of DM2 on health care has also increased because of the intensified cardiovascular risk management being practiced to prevent macrovascular morbidity and mortality in these patients.5 In the treatment of DM2, tight guidelines are increasingly recommended for optimizing glycaemia, blood pressure and lipid profile.6 Therefore, the burden of treatment has increased and will further increase per patient as well as per population with DM2. In order to meet this problem, we tested, in the current study, the hypothesis that well defined routine aspects in diabetes care, previously handled only by medical doctors in secondary care setting, may be safely transferred to supervised nurses specialized in diabetes (NSD), including the prescription of medication, resulting in at least the same quality of clinical care, health care costs, health related quality of life (HRQOL), and patient satisfaction.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
Keywords
Randomized controlled trial, Delegation, Professional, Nurses
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
81 (false)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
Treated and educated by nurses specialized in diabetes.
Primary Outcome Measure Information:
Title
mean decrease in:
Title
HbA1c
Title
blood pressure
Title
total cholesterol
Title
LDL cholesterol
Title
cholesterol/HDL-ratio
Title
proportion of patients achieving ranges of:
Title
glycaemic control
Title
lipid profile
Secondary Outcome Measure Information:
Title
health related quality of life (HRQOL)
Title
diabetes related symptoms
Title
patients' satisfaction
Title
health care consumption and costs
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients with DM2 who were referred by GPs to the diabetes outpatient clinics
Exclusion Criteria:
macroalbuminuria
serum creatinine level > 135 mol/l,
Cockcroft < 50 ml/min
alanine aminotransferase (ALT) > 120 U/l
pregnant woman
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sebastiaan T Houweling, PhD
Organizational Affiliation
2. Department of General Practice, University of Groningen, Groningen, The Netherlands
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Betty Meyboom-de Jong, PhD
Organizational Affiliation
Department of General Practice, University of Groningen, Groningen, The Netherlands
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Henk Bilo, PhD
Organizational Affiliation
3. Centre of Excellence, Isala Clinics, Zwolle, The Netherlands
Official's Role
Study Chair
Facility Information:
Facility Name
Isala Clinics
City
Zwolle
ZIP/Postal Code
8025 AB
Country
Netherlands
12. IPD Sharing Statement
Learn more about this trial
The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes
We'll reach out to this number within 24 hrs